Blueberries Medical Corp.
BBM
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 31.01% | 9.77% | -2.98% | -12.65% | -5.47% |
| Total Depreciation and Amortization | -30.94% | 5.46% | 26.05% | -30.69% | -51.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -51.64% | 335.14% | 387.44% | 279.77% | 353.24% |
| Change in Net Operating Assets | 99.46% | 60.07% | 123.06% | 5.69% | -246.77% |
| Cash from Operations | 41.16% | 42.92% | 47.50% | 26.55% | 13.28% |
| Capital Expenditure | -- | 97.53% | 93.59% | -590.48% | -- |
| Sale of Property, Plant, and Equipment | -67.80% | -187.80% | -186.74% | -74.47% | -74.47% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -97.67% | -35.16% | -20.04% | 265.60% | 253.42% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 99.87% | -2,175.41% | -1,517.09% | -1,887.27% | -1,571.08% |
| Issuance of Common Stock | -- | 35.09% | 35.09% | 35.09% | 35.09% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 71.75% | 74.49% | 74.49% | 74.49% |
| Cash from Financing | -100.38% | -57.85% | -57.85% | -59.15% | -59.97% |
| Foreign Exchange rate Adjustments | 120.15% | -238.81% | -- | -469.70% | -300.30% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -24.17% | -172.78% | -224.25% | -2,929.73% | -14,640.00% |